UNIVERSAL HEALTH SERVICES INC
UHSUniversal Health Services, Inc. (UHS) is an American Fortune 500 company that provides hospital and healthcare services, based in King of Prussia, Pennsylvania. In 2024, UHS reported total revenues of $15.8 billion.
Drugs in Pipeline
0
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
1 upcoming, 2 past
UHS — Stock Offering (424B5)
Priced securities offering (SEC Form 424B5) — potential dilution event.
SourceHow UHS's past catalysts played out
No drugs found in this phase.
Full breakdown — the signals behind the verdict
Frequently asked questions
When is UNIVERSAL HEALTH SERVICES INC's next FDA catalyst?→
UNIVERSAL HEALTH SERVICES INC's (UHS) next tracked catalyst is a Offering expected August 10, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track UHS biotech catalysts?→
Add UHS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow UNIVERSAL HEALTH SERVICES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.